Mesoblast Limited (OTCMKTS:MEOBF – Get Free Report) shares passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.77 and traded as high as $1.00. Mesoblast shares last traded at $0.98, with a volume of 1,290 shares.
Mesoblast Stock Performance
The business has a 50 day moving average price of $0.86 and a two-hundred day moving average price of $0.78.
About Mesoblast
Mesoblast Limited engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage cells.
Featured Stories
- Five stocks we like better than Mesoblast
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- How Whitestone REIT is Transforming Sunbelt Retail Growth
- What is a support level?
- Top-Performing Non-Leveraged ETFs This Year
- The How and Why of Investing in Gold Stocks
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
Receive News & Ratings for Mesoblast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesoblast and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.png?v=20221109115655&h=45&w=95&zc=2){kind=logo}
